Osborne Clarke Amsterdam advises Sofinnova Ventures and Ysios Capital in the USD 30 million Series B Financing of BioClin Therapeutics
International legal practice Osborne Clarke advised Sofinnova Ventures and Ysios Capital in the USD 30 million Series B Financing of...
Published on
23/03/2017
Read time
1m